Call for posters
Advancing Pulmonary Clinical Trials
Share your latest scientific insights, clinical trial data, and methodological innovations with a global, multidisciplinary audience of pulmonologists, clinical investigators, trialists, regulators, and industry leaders committed to advancing pulmonary medicine.
Poster presentations are a central component of the meeting, providing a dynamic forum to present high-quality clinical research, stimulate discussion, and foster collaboration across academia, industry, and regulatory stakeholders.
Why Submit a Poster?
Submitting a poster offers a unique opportunity to:
Present cutting-edge clinical trial data and innovative methodologies
Receive feedback from internationally recognized experts in pulmonary medicine
Increase the visibility and impact of your research
Engage with key stakeholders shaping the future of pulmonary clinical trials
Build new academic and industry collaborations
Posters will be displayed during dedicated poster sessions designed to encourage in-depth scientific exchange and networking.
Scope of Poster Presentations
Poster submissions may include, but are not limited to:
Scientific rationale, study design, and key methodological features of planned, ongoing, or recently initiated clinical trials in pulmonary medicine
Primary results from early-phase and proof-of-concept studies, including first-in-human and exploratory trials
Secondary, exploratory, or subgroup analyses from major Phase III clinical trials whose primary results have been recently published or presented as late-breaking or hotline sessions at major international scientific meetings
Results from newly conducted meta-analyses addressing clinically relevant questions in pulmonary medicine and respiratory clinical research
Submissions from academic institutions, clinical research networks, industry sponsors, and collaborative partnerships are strongly encouraged.
Topics of Interest
Posters may address clinical trials and research across all areas of pulmonary medicine, including but not limited to:
COPD, asthma, and airway diseases
Interstitial lung diseases and pulmonary fibrosis
Pulmonary hypertension
Rare pulmonary disorders
Lung cancer clinical trials
Sleep and respiratory disorders
Innovative trial designs and methodologies
Biomarkers, endpoints, and real-world evidence
Ethics, diversity, and patient-centered outcomes in clinical trials
Submission and Review
All submitted abstracts will undergo peer review by the Scientific Committee based on scientific quality, relevance, and innovation. Accepted posters will be presented during the conference poster sessions.
Submit Your Poster
We invite investigators, clinicians, and industry partners to contribute to this important scientific exchange and help shape the future of pulmonary medicine clinical trials.